[1]
“Quantifying the Impact of Real-World Evidence: The Sacubitril/Valsartan Experience”, acbr, vol. 9, no. 6, pp. 559–561, Dec. 2025, Accessed: Sep. 17, 2026. Available: https://fortunejournals.org/ojs/index.php/acbr/article/view/15157